Enhanced tumor cell killing was attributed, at least in part, to the expression of shRNAs targeting HSP27 and TGF-β1, which synergistically repressed tumor survival, reduced expression of tumor progression-related proteins, and concomitantly increased viral replication. Here, TGFB1 is linked to neoplasm.